Studying recovery after nerve damage from NOS use
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how neurological symptoms (like numbness, weakness, unsteadiness, or walking problems) recover after damage caused by NOS use. It may help researchers understand what recovery looks like and what support or treatments could work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 16 and 40 years old (as of 19/08/2024)
- Have new or past numbness/tingling, weakness, balance problems, or trouble walking that started after NOS use
- Have a confirmed diagnosis from a specialist neurologist that your nerve/brain injury is caused by NOS
- Be able to read and write in English to fill out questionnaires
- You should not have nerve/brain symptoms caused by another known illness (not NOS)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nitrous oxide (also called laughing gas) is detected and how health effects may show up over time. It may help doctors better diagnose problems early and track changes after use.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study looks at vision problems that are linked to the brain and nerves, specifically for people who have been diagnosed with NO. By reviewing your medical data, researchers hope to better understand this condition and improve care.
This study helps doctors better understand and measure sensory nerve damage (nerves that feel pain, temperature, and touch). You may qualify if you have a specific type of nerve damage caused by cancer, autoimmune disease, platinum chemotherapy, or a rare genetic condition.
This study collects information from people who may have a nerve or muscle problem or a nerve-degenerating illness, based on the usual care they already receive. It may help researchers understand symptoms and test results in real-world patients.
This study is a long-term observational study—it does not test a new drug but follows people with certain nerve and immune conditions (like multiple sclerosis, myasthenia gravis, and others) to learn more about how these diseases progress. By joining, you help researchers gather valuable data that could improve care for others with similar conditions.
Hear when a new Paresthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.